- Australian Dollar: AAA rating intact but growth risks linger – BNY
- Analyst Who Accurately Called 2024 XRP Price Rally Drops Fresh Prediction
- Altcoin Open Interest Drops 15% as Bitcoin Dominance Deepens
- Annexon says tanruprubart shows rapid strength gains in first 10 GBS FORWARD study patients
- Rezolve Ai publishes update to financial calendar
- LENSAR to report Q2 2026 results, host conference call
- Twin Vee Q2 FY26 net loss widens 75% to $2.9 million; net sales drop 34% to $3.13 million
- Corbus Q2 FY26 net loss widens to $35.04 million; loss per share increases to $1.81
- Prime Medicine Q2 FY26 net loss narrows to $42.1 million
- NextTrip partners with KC Global Media to expand JOURNY TV across Asia-Pacific, Middle East and Africa
- Latham Group CEO, CFO to join Barclays Building & Building Products Conference Q&A session
- Koppers Q2 FY26 turns to loss of $147.5 million; net sales rise 3% to $520.1 million
- Zscaler schedules fiscal Q4 2026 earnings call
- Deutz managing body member Sebastian C. Schulte buys shares worth EUR 983,089
- Quirin Privatbank reiterates Buy on Deutz, sets target price at EUR 14
- Burford Capital announces 2Q26, YTD26 financial results in Form 8-K
- Guerrilla RF Q2 FY26 operating income swings to $1 million; revenue rises 49% to $8 million
- Xunlei schedules Q2 earnings release, conference call
- ALX Oncology Q2 FY26 GAAP net loss narrows to $18 million; R&D expenses fall 27.2% to $13.1 million
- Belite Bio schedules webcast to discuss Q2 financial results
- Mira Pharma reports positive 7-day dog toxicokinetic study results for obesity drug candidate SKNY-1
- Aligos Q2 FY26 net loss narrows 91% to $1.5 million
- E.L.F. BEAUTY, INC. <ELF.N>: BERNSTEIN RAISES TARGET PRICE TO $121 FROM $113
- Tejon Ranch Q2 FY26 swings to net profit of $2.6 million; revenue rises 56.76% to $17.4 million
- Bitcoin AI Security Audit Files 4,962 Findings Across 390 Projects
- BRIEF-Insight Enterprises Q2 EPS USD 2.57
- BRIEF-Ralph Lauren Q1 Revenue USD 2,000 Million Vs. IBES Estimate USD 1,867 Million
- BRIEF-Delcath Systems Q2 Revenue USD 29.133 Million Vs. IBES Estimate USD 26.3 Million
- Zhengye Biotechnology regains Nasdaq compliance with $1 minimum bid price rule
- Enad Global 7 to host live presentation and Q&A on Q2 interim report
- Copper 360 appoints Neal Froneman as board chair
- Douglas Elliman to host conference call on second-quarter 2026 results
- Kingsoft Cloud to release Q2 2026 results before US market open
- U.S. Treasury bonds declined; earlier, British media reported that Federal Reserve Chair Waller may prepare for a rate hike in September if inflation remains strong. In addition, Alphabet (GOOG.US) launched a ten-part U.S. dollar investment-grade bond issuance.
- Alphabet (GOOG.US) launches 10-tranche US dollar investment grade bond issuance.
- Digia H1 EBITA drops 16.7% to EUR 6.4 million; net sales rise 2.9% to EUR 110.7 million
- Sempra Q2 FY26 GAAP earnings rise 72.67% to $796 million
- Xtant Medical schedules Q2 results conference call
- BRIEF-Fox Q4 Revenue USD 4,210 Million Vs. IBES Estimate USD 3,643 Million
- BRIEF-ALX Oncology Q2 Basic EPS USD -0.13
- BRIEF-Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
- BRIEF-Hertz Q2 Adjusted EPS USD -0.11 Vs. IBES Estimate USD -0.24
- BRIEF-Prime Medicine, Inc. Q2 EPS USD -0.24
- BRIEF-Marcus & Millichap Q2 Revenue USD 202.915 Million
- BRIEF-Praxis Precision Q2 EPS USD -2.87
- BRIEF-Tejon Ranch Q2 EPS USD 0.1
- BRIEF-USA TODAY Co Inc Q2 Revenue USD 536.337 Million Vs. IBES Estimate USD 546.7 Million
- BRIEF-Helix Energy Solutions Q2 EPS USD 0.15
- Cion Investment 2Q EPS 62c >CION
- Fox Corp. 4Q Cable Network Programming Revenue $1.67B >FOXA
- Fox Corp. 4Q Rev $4.21B >FOXA
- Fox Corp. 4Q EPS $1.61 >FOXA
- Fox Corp. 4Q Television Revenue $2.48B >FOXA
- Amphenol Announces Two-for-One Stock Split And Third Quarter 2026 Dividend >APH
- Globalstar 2Q Rev $64.8M >GSAT
- Corbus Pharmaceuticals 2Q Loss/Shr $1.81 >CRBP
- Marcus & Millichap 2Q Net $3.91M >MMI
- Marcus & Millichap 2Q Rev $202.9M >MMI
- Novavax 2Q Loss/Shr 32c >NVAX
- Novavax 2Q Loss $53.4M >NVAX
- Novavax 2Q Rev $56.7M >NVAX
- Helix Energy Solutions 2Q EPS 15c >HLX
- Helix Energy Solutions 2Q Net $22.7M >HLX
- Tejon Ranch 2Q Rev $14.3M >TRC
- NetApp Acquires JetStream Software To Advance Cyber Resilience And Data Protection For The AI Era >NTAP
- BioVie posts corporate presentation outlining bezisterim and BIV201 clinical programs
- Sabre posts Q2 2026 earnings release, presentation on investor relations website
- PHILLIPS 66 : RAYMOND JAMES RAISES TARGET PRICE TO $240 FROM $235
- AMGEN INC : BERNSTEIN RAISES TARGET PRICE TO $345 FROM $335
- PAR PACIFIC HOLDINGS INC : RAYMOND JAMES RAISES TARGET PRICE TO $90 FROM $85
- Karooooo CEO, Executive Chairman IJ Calisto disposes of USD 3.89 million in common shares
- InflaRx posts H1 loss as warrant fair-value hit outweighs FX gains, R&D spending falls
- SSR MINING INC. <SSRM.TO>: NATIONAL BANK OF CANADA RAISES TARGET PRICE TO C$67 FROM C$57
- The US dollar against the Swiss franc has just reached the 0.8100 mark, now quoted at 0.8100, up 0.37% for the day.
- JANUS LIVING INC <JAN.N>: RAYMOND JAMES RAISES TARGET PRICE TO $40 FROM $34
- BRIEF-Sempra Q2 Adjusted EPS USD 1.16 Vs. IBES Estimate USD 1.06
- BRIEF-Koppers Q2 Adjusted EPS USD 1.37 Vs. IBES Estimate USD 1.12
- SANDISK CORPORATION <SNDK.O>: SUSQUEHANNA CUTS TARGET PRICE TO $2745 FROM $3050
- Sempra Sees FY EPS $5.02-EPS $5.55 >SRE
- Koppers 2Q Loss/Shr $7.71 >KOP
- Koppers 2Q Sales $520.1M >KOP
- Koppers 2Q Adj EPS $1.37 >KOP
- Sempra Sees FY Adj EPS $4.80-Adj EPS $5.30 >SRE
- Oroco drills 26.48 m at 1.18% CuEq in Santo Tomas South Zone, Mexico
- Novavax Q2 FY26 turns to net loss of $53.39 million; revenue drops 76.29% to $56.7 million
- Agenus advances Phase 3 ROBBIN trial of botensilimab-balstilimab in neoadjuvant MSS colon cancer
- argenx launches tender offer for Forte Biosciences at $77 a share
- WYNN RESORTS, LIMITED <WYNN.O>: ARGUS RESEARCH RAISES TARGET PRICE TO $130 FROM $115
- INSULET CORPORATION : RAYMOND JAMES CUTS TARGET PRICE TO $180 FROM $216
- ADVANCED MICRO DEVICES : ARGUS RESEARCH RAISES TARGET PRICE TO $625 FROM $450
- BRISTOW GROUP INC. <VTOL.N>: RAYMOND JAMES RAISES TARGET PRICE TO $67 FROM $60
- AVNET INC : RAYMOND JAMES RAISES TARGET PRICE TO $120 FROM $95
- Charter upsizes debt exchange offers, raises new secured notes caps to USD 2 billion each
- Cairo Communication says H1 2026 half-year financial statement is filed
- ROPER TECHNOLOGIES, INC. <ROP.O>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- Helleniq Energy releases transcript of Q2 and H1 2026 results call
- Becton Dickinson Sees FY Adj EPS $12.62-Adj EPS $12.72 >BDX
- Becton Dickinson 3Q Rev $4.98B >BDX
- Becton Dickinson 3Q EPS $1.37 >BDX
- Becton Dickinson 3Q Net $377M >BDX
